Exco InTouch Predict Huge Increase in Full-Scale mHealth Programs in 2015
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, predict that 2015 will see a significant shift from piloting mHealth programs through to full-scale implementation. The new trend towards scale up and rising demand for multinational patient support services is driven by increased confidence in the proven capability of cross-border mHealth programs to deliver more cost effective care and to significantly improve healthcare outcomes.
The market is consequently moving away from pilots and is set for a massive shift towards full-scale mHealth programs. However, delivering them presents unique challenges which must be addressed. The multitude of varying and complex regulations and differing patient requirements for the precise form of mobile and digital technology to be applied requires providers to be highly adaptable, and to have strong regional knowledge. Exco InTouch have led the drive to overcome these challenges by developing efficient frameworks and detailed action plans that leverage advanced systems, technology and knowledge to enable full-scale implementation of cross-border mHealth solutions.
Bringing mHealth solutions from pilots to full-scale programs requires taking a number of key considerations into account, including the background architecture of a potential program, such as regional settings and date formats, as well as the operational and technology considerations, such as ensuring that correct mechanisms are in place to handle cross-border data, building robust support mechanisms in at program source and ensuring multi-threading and asynchronous processing. In adddition, scaling up mHealth programs requires the ability to monitor and identify system bottlenecks and planning for infrastructure to manage increased capacity. Finally, when planning for a cross-border implementation, it is vital to remember that patients need to be kept central to all design decisions.
Regulatory compliance and knowledge is aiding the scale up of cross-border mHealth programs. Providers are increasingly able to build different data protection requirements across multiple geographies into mHealth solutions at source. Exco InTouch, for example, has emerged as the only mHealth solutions provider to comply with HIPAA, Safe Harbor and EU Data Protection Regulations, which are required in the cross-border implementation.
Dr Chris Watson, Product Manager at Exco InTouch commented: "Full-scale cross-border mHealth solutions will expand significantly as the capability for carrying them out with great effectiveness is becoming massively enhanced.
He continued: “Pilot projects have been crucial to hone the technology and comply with different regulations encountered, but the essential requirements and conditions are now in place for the industry to confidently scale-up to full scale mHealth programs.
Tim Davis, CEO and Founder of Exco InTouch commented: “We have seen forward thinking providers become more flexible, responsive and confident towards rolling mHealth programs across borders. The results speak for themselves and the proven capability of leading mHealth providers to overcome industry challenges, combined with the scale of their proven ability to enhance cost effectiveness whilst improving patient outcomes, is driving demand for such programs from both patients and sponsors. Consequently, the next 12 months will be the time when mHealth finally breaks free and spans the world to improve health outcomes on a global scale.”
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance